Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | FLAMSA-reduced intensity vs myeloablative conditioning for R/R AML with disease at transplantation

Eduardo Rodríguez-Arbolí • 31 Aug 2020
EBMT 2020
Acute Myeloid Leukemia Leukemia

Eduardo Rodríguez-Arbolí, MD, MPhil, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC/CIBERONC), University of Seville, Seville, Spain, discusses FLAMSA-based reduced-intensity conditioning versus myeloablative conditioning in patients with relapsed/refractory (R/R) acute myeloid leukemia (AML) with active disease at transplantation. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Eduardo Rodríguez-Arbolí

5:00
Phase I trial of glasdegib in refractory sclerotic chronic GvHD
Eduardo Rodríguez-Arbolí • 27 May 2021

Related Videos

2:24
Manipulating the gut microbiome to improve outcomes of alloSCT for hematological malignancies
Florent Malard • 11 Apr 2024
2:05
Investigating mutation order in AML using single-cell sequencing
Ravindra Majeti • 8 Apr 2024
3:12
An epitope editing approach to enable the use of targeted immunotherapy in AML
Gabriele Casirati • 9 Apr 2024
0:59
Developing LSC-targeting agents in AML: progress and current therapeutic capacity
Ravindra Majeti • 8 Apr 2024
The content of VJHemOnc is intended for healthcare professionals